GeneDx

WGS

1 Obserwujący

$56.36

-1.71%

-$0.98

Obserwuj

29 Lipiec

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

WGS Fair Price

$59.43

Undervalued by 53.3%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

My Notes

Začít psát

Profile

GeneDx is a biotechnology company specializing in genomic testing, particularly exome and genome sequencing, aimed at diagnosing rare and ultra-rare genetic disorders. Founded in 2000, the company is headquartered in Gaithersburg, Maryland. In 2021, GeneDx merged with Sema4 Holdings, strengthening its position in genomic testing. In 2024, the company achieved a significant financial turnaround, reporting its first adjusted net income in the third quarter and a year-over-year revenue increase of 52% to $76.6 million. GeneDx's shares are traded on NASDAQ under the symbol WGS.

Feed

There are no posts to show right now.